drugset / Trial / NCT07565090
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Phase 1
Recruiting
112 enrolled
International AIDS Vaccine Initiative
Biomedical Advanced Research and Development Authority · collab
RandomizedSingle-groupTriple-blindPrevention
Summary
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health.
Timeline
- Start
- 2026-05-08
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rVSVΔG-SUDV-GP | Vaccine | 2e+06 unknown | — |
| Subject | rVSVΔG-SUDV-GP | Vaccine | 1e+07 unknown | — |
| Subject | rVSVΔG-SUDV-GP | Vaccine | 2e+07 unknown | — |
| Subject | rVSVΔG-SUDV-GP | Vaccine | 5e+07 unknown | — |